Aroyl-piperazine derivatives, their preparation and their...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S227800, C514S228200, C514S235800, C514S253030, C544S060000, C544S062000, C544S121000, C544S369000

Reexamination Certificate

active

06924278

ABSTRACT:
This invention relates to piperazine derivatives of the formula:wherein each symbol is as defined in the description, and its pharmaceutically acceptable salt, to processes for preparation thereof, to pharmaceutical composition comprising the same, and to a use of the same for treating or preventing Tachykinin-mediated diseases in human being or animals.

REFERENCES:
patent: 5670505 (1997-09-01), Matsuo et al.
patent: 5883098 (1999-03-01), Matsuo et al.
patent: 5939413 (1999-08-01), Matsuo et al.
patent: 6087357 (2000-07-01), Matsuo et al.
patent: 655442 (1995-05-01), None
patent: 9630343 (1996-10-01), None
patent: 9634864 (1996-11-01), None
patent: 9637489 (1996-11-01), None
patent: 9708166 (1997-03-01), None
patent: 9722597 (1997-06-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aroyl-piperazine derivatives, their preparation and their... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aroyl-piperazine derivatives, their preparation and their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aroyl-piperazine derivatives, their preparation and their... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3482875

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.